Role of nanobiotechnology in developing personalized medicine for cancer

被引:61
作者
Jain, KK [1 ]
机构
[1] Jain PharmaBiotech, CH-4057 Basel, Switzerland
关键词
cancer; personalized medicine; nanoparticles; nanotechnology; nanobiotechnology; cancer therapy; cancer diagnosis; drug delivery in cancer; nano-diagnostics; and drug discovery;
D O I
10.1177/153303460500400608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Personalized medicine simply means the prescription of specific therapeutics best suited for an individual. Personalization of cancer therapies is based on a better understanding of the disease at the molecular level. Nanotechnology will play an important role in this area. Nanobiotechnology is being used to refine discovery of biomarkers, molecular diagnostics, drug discovery and drug delivery, which are important basic components of personalized medicine and are applicable to management of cancer as well. Examples are given of the application of quantum dots, gold nanoparticles, and molecular imaging in diagnostics and combination with therapeutics - another important feature of personalized medicine. Personalized medicine is beginning to be recognized and is expected to become a part of medical practice within the next decade. Personalized management of cancer, facilitated by nanobiotechnology, is expected to enable early detection of cancer, more effective and less toxic treatment increasing the chances of cure.
引用
收藏
页码:645 / 650
页数:6
相关论文
共 26 条
[1]   Protease-activated quantum dot probes [J].
Chang, E ;
Miller, JS ;
Sun, JT ;
Yu, WW ;
Colvin, VL ;
Drezek, R ;
West, JL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (04) :1317-1321
[2]   Targeting cancer cells with DNA-Assembled dendrimers - A mix and match strategy for cancer [J].
Choi, Y ;
Baker, JR .
CELL CYCLE, 2005, 4 (05) :669-671
[3]   Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer [J].
El-Sayed, IH ;
Huang, XH ;
El-Sayed, MA .
NANO LETTERS, 2005, 5 (05) :829-834
[4]   Tumor regression by targeted gene delivery to the neovasculature [J].
Hood, JD ;
Bednarski, M ;
Frausto, R ;
Guccione, S ;
Reisfeld, RA ;
Xiang, R ;
Cheresh, DA .
SCIENCE, 2002, 296 (5577) :2404-2407
[5]   Personalised medicine for cancer: from drug development into clinical practice [J].
Jain, KK .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (09) :1463-1476
[6]   The role of nanobiotechnology in drug discovery [J].
Jain, KK .
DRUG DISCOVERY TODAY, 2005, 10 (21) :1435-1442
[7]   Nanotechnology-based drug delivery for cancer [J].
Jain, KK .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (04) :407-416
[8]   Role of oncoproteomics in the personalized management of cancer [J].
Jain, KK .
EXPERT REVIEW OF PROTEOMICS, 2004, 1 (01) :49-55
[9]  
Jain KK, 2002, CURR OPIN MOL THER, V4, P548
[10]  
JAIN KK, 2005, ENCY DIAGNOSTIC GENO, P994